Lorin Randall is Director at ACORDA THERAPEUTICS INC (ACOR). They have made 6 open-market trades across 3 companies since 2009, most recently 2018-11-26.
CIK 0001352452
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACOR | SELL | 2018-11-26 | 2018-11-28 | $19.98 | $38K | -22.3% | -27.9% | -32.7% |
| ACOR | SELL | 2017-07-31 | 2017-08-02 | $21.66 | $217K | -2.9% | -2.7% | +19.2% |
| ACOR | SELL · 10b5-1 | 2016-04-19 | 2016-04-21 | $28.68 | $43K | -13.4% | -10.2% | -12.5% |
| ATHX | SELL | 2014-08-18 | 2014-08-19 | $1.54 | $23K | +5.0% | +0.0% | +0.0% |
| TNGN | SELL | 2013-09-04 | 2013-09-06 | $0.63 | $239 | N/A | N/A | N/A |
| ACOR | SELL | 2012-11-28 | 2012-11-30 | $24.70 | $252K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2011-05-20 | 2011-05-23 | $31.60 | $79K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2011-01-10 | 2011-01-11 | $30.00 | $150K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2010-08-11 | 2010-08-12 | $33.52 | $168K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL | 2009-08-12 | 2009-08-13 | $23.58 | $236K | -8.7% | +0.7% | +0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.